Radiology AI devices are more likely to face FDA recalls, largely due to deviations from intended use and incomplete clinical data.
Key Details
- 1New analysis looked at 903 healthcare AI devices approved by FDA between 1995 and 2024.
- 2Of these, 5% (43 devices) were recalled, with a median recall interval of 458 days.
- 3Radiology comprised 692 of these devices, with a 4.3% (30 devices) recall rate.
- 4Radiology AI devices are 52% more likely to face recall than AI devices in other specialties.
- 5Missing clinical study information and deviations from intended use were major risk factors for recall.
- 6Problems with temperature and labeling led to lower recall risk, while market surveillance flags increased it.
Why It Matters
This study is the first to systematically quantify recall risk factors for AI-enabled devices, highlighting the urgent need for rigorous validation and postmarket surveillance, especially within radiology. Increased transparency and robust premarket evaluation may help mitigate safety risks as AI adoption accelerates.
Source
Radiology Business
Related News
•Radiology Business
Real-World Study: Radiology AI Best in Emergency and Inpatient Settings
A commercial AI tool for intracranial aneurysm detection outperformed in inpatient and emergency settings but yielded limited benefits for outpatients in a major health system study.
•Radiology Business
New Rubric Enhances Safety of AI-Generated Radiology Summaries
Researchers developed a five-factor rubric to assess the safety and quality of AI-generated, patient-friendly radiology report summaries.
•Radiology Business
AI Model Surpasses Radiologists in Detecting Subtle Hip Fractures
A new AI model outperformed radiologists in identifying difficult-to-detect femoral neck fractures on radiographs.